ICONIC Study Collecting Clinical Data and Samples to Improve Outcomes for Osteosarcoma Patients of All Ages

What this Trial Is About

Researchers are studying osteosarcoma, the most common type of bone cancer, which affects people of all ages with peaks in adolescence and over 60 years. Despite various treatments like chemotherapy and surgery, survival rates have not improved much in the last 25 years. This study aims to collect detailed clinical data and biological samples to better understand how osteosarcoma develops, spreads, and responds to treatment, with the goal of improving care and developing new therapies. Participants will receive standard care treatments as determined by their doctors. This observational study does not prescribe any specific treatments but collects information on disease characteristics, treatment types, and patient outcomes. Blood and tissue samples will be gathered for laboratory analysis, while patient-reported outcomes and quality of life measures will also be collected to assess the impact of osteosarcoma and its treatments. Throughout the study, researchers will monitor clinical data, treatment responses, and laboratory findings to explore factors affecting disease progression and patient survival. Patient recruitment is planned over several years, with ongoing data collection and analysis. The study duration varies per participant, focusing on understanding osteosarcoma across all ages and tumor types to guide future clinical trials and improve patient support.

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa